These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25964858)

  • 21. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
    Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
    Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and functional characterization of MDSC-like cells.
    Heine A; Held SAE; Schulte-Schrepping J; Wolff JFA; Klee K; Ulas T; Schmacke NA; Daecke SN; Riethausen K; Schultze JL; Brossart P
    Oncoimmunology; 2017; 6(4):e1295203. PubMed ID: 28507805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
    Lee KJ; Lee KY; Lee YM
    Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
    Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
    Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Yan D; Zhang M; Wang L; Adeshakin FO; Liu W; Wan X
    Biochem Biophys Res Commun; 2020 Feb; 522(3):604-611. PubMed ID: 31785814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
    Chiu DK; Xu IM; Lai RK; Tse AP; Wei LL; Koh HY; Li LL; Lee D; Lo RC; Wong CM; Ng IO; Wong CC
    Hepatology; 2016 Sep; 64(3):797-813. PubMed ID: 27228567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
    Draghiciu O; Lubbers J; Nijman HW; Daemen T
    Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factor-1α inhibits interleukin-6 and -8 production in gingival epithelial cells during hypoxia.
    Takedachi M; Iyama M; Sawada K; Mori K; Yamamoto S; Morimoto C; Yanagita M; Murakami S
    J Periodontal Res; 2017 Feb; 52(1):127-134. PubMed ID: 27016382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells.
    Xiao W; Klement JD; Lu C; Ibrahim ML; Liu K
    J Immunol; 2018 Jul; 201(1):264-277. PubMed ID: 29752314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death-ligand 1 expression by reducing hypoxia-inducible factor-1α and STAT3.
    Xing Y; Mi C; Wang Z; Zhang ZH; Li MY; Zuo HX; Wang JY; Jin X; Ma J
    Pharmacol Res; 2018 Sep; 135():166-180. PubMed ID: 30103001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.
    Fleming V; Hu X; Weller C; Weber R; Groth C; Riester Z; Hüser L; Sun Q; Nagibin V; Kirschning C; Bronte V; Utikal J; Altevogt P; Umansky V
    Cancer Res; 2019 Sep; 79(18):4715-4728. PubMed ID: 31337655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling.
    Tsai MS; Chen WC; Lu CH; Chen MF
    Oral Oncol; 2019 Apr; 91():47-55. PubMed ID: 30926062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape.
    Wen Q; Han T; Wang Z; Jiang S
    Oncol Lett; 2020 Apr; 19(4):2595-2601. PubMed ID: 32218809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of hypoxia-inducible factor-1 alpha in the regulation of plasminogen activator activity in rat knee joint chondrocytes.
    Zhu G; Tang Y; Liang X; Zheng M; Yang J; Zhou H; Li L; Qin T
    Osteoarthritis Cartilage; 2009 Nov; 17(11):1494-502. PubMed ID: 19490965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent hypoxia-induced PD-L1 upregulation in patients with obstructive sleep apnoea.
    Cubillos-Zapata C; Balbás-García C; Avendaño-Ortiz J; Toledano V; Torres M; Almendros I; Casitas R; Zamarrón E; García-Sánchez A; Feliu J; Aguirre LA; Farre R; López-Collazo E; García-Rio F
    Respirology; 2019 Jul; 24(7):684-692. PubMed ID: 30656807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of hypoxia-inducible factor-1alpha in hypoxia-induced apoptosis of primary alveolar epithelial type II cells.
    Krick S; Eul BG; Hänze J; Savai R; Grimminger F; Seeger W; Rose F
    Am J Respir Cell Mol Biol; 2005 May; 32(5):395-403. PubMed ID: 15695738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
    Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
    Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
    Komura N; Mabuchi S; Shimura K; Yokoi E; Kozasa K; Kuroda H; Takahashi R; Sasano T; Kawano M; Matsumoto Y; Kodama M; Hashimoto K; Sawada K; Kimura T
    Cancer Immunol Immunother; 2020 Dec; 69(12):2477-2499. PubMed ID: 32561967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior.
    Pinato DJ; Black JR; Trousil S; Dina RE; Trivedi P; Mauri FA; Sharma R
    Oncoimmunology; 2017; 6(11):e1358332. PubMed ID: 29147618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.